Researchers show ovarian cancer is a group of distinct diseases

Scientists from the Ovarian Cancer Research Program (OvCaRe) and V ancouver Coastal Health Research Institute have identified distinct pathways for five subtypes of ovarian cancer, showing they are completely different diseases. The discovery will lead to new avenues for early detection and more effective customized treatments for women with ovarian cancer.

Human breast stem cells that regrow mammary tissue

A team of Agency researchers showed that the normal female breast contains breast stem cells that can regenerate a complete miniature, milk-producing mammary gland after being transplanted. These normal breast stem cells may be the culprits that start to form breast cancers.

BC Cancer Agency study sheds new light on controlling oral cancer

The hand-held oral cancer device called the VELscope, invented and developed at the Agency for the detection and treatment of oral precancerous lesions, achieved FDA and Health Canada approval, went into production and was introduced to dentists in B.C. and around the world for enhanced oral cancer screening

New technology developed at BC Cancer Agency may revolutionize radiation therapy delivery

The Agency developed a revolutionary technology called Volumetric Modulated Arc Therapy (VMAT) that will enable cancer patients to receive faster and more precise radiation therapy through a single 360-degree rotation of the radiation beam around the body. VMAT involves an innovative method for manipulating the radiation beams that can be delivered from a standard linear accelerator (a machine...

Smoking causes irreversible gene damage

Researchers discovered new evidence that explained why former smokers are still susceptible to lung cancer after they have stopped smoking for many years. The study showed that in former smokers, some genes return to levels similar to people who never smoked, while other genes appear to be permanently damaged

Stem cell subtypes discovered by BC Cancer Agency

Researchers discovered that there are distinct subtypes of blood stem cells. Each stem cell behaves uniquely and produces different types of mature blood cells in a transplant setting. This may lead to improved treatments for leukemia patients.